5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release-Reference-Cited by-同舟云学术

5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

Published:2001-12-20 Issue:5 Volume:76 Page:1521-1531
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Ichikawa Junji,Ishii Hideo,Bonaccorso Stefania,Fowler Wiley L.,O'Laughlin Ian A.,Meltzer Herbert Y.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1471-4159.2001.00154.x/fullpdf

Reference58 articles.

1. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system;Andersson;Naunyn-Schmiedeberg's Arch. Pharmacol.,1995

2. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex;Araneda;Neuroscience,1991

3. The 5-HT1A receptor selective ligands, R (+)-8-OH-DPAT and (S)-UH 301, differentially affect the activity of midbrain dopamine neurons;Arborelius;Naunyn-Schmiedeberg's Arch. Pharmacol.,1993

4. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence;Arnt;Neuropsychopharmacology,1998

5. Electrophysiological evidence for a functional interaction between 5-HT1a and 5-HT2a receptors in the rat medial prefrontal cortex: an iontophoretic study;Ashby;Synapse,1994

Cited by 449 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysis;Schizophrenia Research;2024-08

2. Modulation of neuronal morphology by antipsychotic drug: Involvement of serotonin receptor 7;Brain Research;2024-05

3. Beyond dopamine: Novel strategies for schizophrenia treatment;Medicinal Research Reviews;2024-04-23

4. Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia;Frontiers in Pharmacology;2024-01-24

5. Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis;Schizophrenia Research: Cognition;2023-12